Impact of three variants of prolonged exposure therapy on comorbid diagnoses in patients with childhood abuse-related PTSD.
Chris Maria HoeboerMarie-Louise J KullbergDanielle A C OprelMaartje SchoorlAgnes van MinnenNiki AntypaJoanne MouthaanRianne De KleineA J Willem van der DoesPublished in: Cognitive behaviour therapy (2024)
Recent studies indicated that Prolonged Exposure (PE) is safe and effective for posttraumatic stress disorder (PTSD). It is unclear whether PE also leads to a reduction in comorbid diagnoses. Data from a large randomized controlled trial ( N = 149) on the effects of three variants of PE for PTSD were used. We examined the treatment effects on co-morbid diagnoses of depressive, anxiety, obsessive compulsive, substance abuse, psychotic, eating and personality disorders in a sample of patients with PTSD related to childhood abuse. Outcomes were assessed with clinical interviews at baseline, post-treatment and at 6- and 12-month follow-up. All variants of PE led to a decrease from baseline to post-treatment in diagnoses of depressive, anxiety, substance use and personality disorders. Improvements were sustained during follow-up. We found an additional decrease in the number of patients that fulfilled the diagnostic criteria of a depressive disorder between 6- and 12-month follow-up. No significant changes were observed for the presence of OCD, psychotic and eating disorders. Findings suggest that it is effective to treat PTSD related to childhood abuse with trauma-focused treatments since our 14-to-16 weeks PE for PTSD resulted in reductions in comorbid diagnoses of depressive, anxiety, substance use and personality disorders.
Keyphrases
- posttraumatic stress disorder
- bipolar disorder
- randomized controlled trial
- social support
- end stage renal disease
- copy number
- clinical trial
- stem cells
- type diabetes
- physical activity
- chronic kidney disease
- ejection fraction
- newly diagnosed
- systematic review
- sleep quality
- peritoneal dialysis
- intimate partner violence
- depressive symptoms
- mesenchymal stem cells
- combination therapy
- weight loss
- young adults
- machine learning
- prognostic factors
- big data
- insulin resistance
- bone marrow
- deep learning
- preterm birth